Showing results (181-190 of 798) with videos related to
Sort By:
Pageof 80
The Journal of Infectious Diseases|February 1, 1994
Quantitation of human immunodeficiency virus by culture and polymerase chain reaction in response to didanosine after long-term therapy with zidovudineD A Katzenstein, M Winters, J Bubp, et al.Infection and Immunity|November 1, 1983
X-linked resistance of mice to high doses of herpes simplex virus type 2 correlates with early interferon productionE B Pedersen, S Haahr, S C MogensenJournal of Neuroimmunology|January 1, 1987
The influence of human allergic encephalitogenic peptide on cell-mediated cytotoxicity reactions in patients with multiple sclerosisA Møller-Larsen, S Haahr, H J HansenGastroenterology|December 1, 1981
Effects of immunosuppressive therapy on viral markers in chronic active hepatitis BG H Scullard, C I Smith, T C Merigan, et al.Acta Neurologica Scandinavica|April 1, 1986
Interferon induction, 2'-5' oligo A synthetase and lymphocyte subpopulations in out-patients with multiple sclerosis in a longitudinal studyS Haahr, A Møller-Larsen, J Justesen, et al.Dansk Medicinhistorisk Arbog|October 20, 2001
[Danish contributions to early cell biology: with a point of departure in films, among others about the inauguration of the biological institute of the Carlsberg Foundation October 19, 1932]L RasmussenTransplant Infectious Disease : an Official Journal of the Transplantation Society|June 29, 2001
Molecular pathogenesis of human cytomegalovirus infectionL RasmussenTrustee : the Journal for Hospital Governing Boards|May 1, 1992
Setting policy on environmental issues. Interview by Karen GardnerL RasmussenDansk Medicinhistorisk Arbog|October 20, 2001
[The Rockefeller Foundation, the Carlsberg Foundation and Danish medical biology in the interwar years. Effects on research and education throughout the 20th century]L RasmussenAIDS Research and Human Retroviruses|October 27, 2001
Effect of therapeutic immunization with HIV type 1 recombinant glycoprotein 160 ImmunoAG vaccine in HIV-infected individuals with CD4+ T cell counts of >or=500 and 200-400/mm3 (AIDS Clinical Trials Group Study 246/946)S Kundu-Raychaudhuri, A Sevin, P Kilgo, et al.Pageof 80